Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer

This study has been terminated.
(limited funding)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Max Sung, Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT00072098
First received: November 4, 2003
Last updated: January 10, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)